Have any questions?
+44 1234 567 890
NEWS
February 27, 2025
Pacira BioSciences, Inc. Acquires GQ Bio Therapeutics GmbH
GQ Bio announces that it has been acquired by Pacira. GQ Bio has been pioneering a high-capacity adenoviral gene therapy vector platform and has a preclinical gene therapy pipeline with disease-modifying potential in prevalent musculoskeletal diseases. This transaction is building on Pacira’s plan to transition into an innovative biopharmaceutical organization. Pacira, who has already been a shareholder in GQ Bio, is acquiring the remaining equity interest of approx. 81% for approx. $32 million, net of working capital and other transaction adjustments.
